Relationship between pre-micro-TESE serum anti-Müllerian hormone (AMH) levels and sperm retrieval success in patients diagnosed with non-obstructive azoospermia: A retrospective study

Objective: We aimed to evaluate the relationship between serum anti-Müllerian hormone (AMH) levels measured before microdissection testicular sperm extraction (mTESE) and sperm retrieval (SR) success in men diagnosed with non-obstructive azoospermia (NOA). Materials and Methods: The present study was based on retrospective evaluation of 58 patients who presented to our clinic between January 2025 and April 2026, were diagnosed with NOA, and underwent mTESE. Patient age, duration of infertility, serum AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH) testosterone levels, and the AMH/testosterone ratio were recorded. Demographic and hormonal parameters were compared between the successful SR (+SR) and unsuccessful SR (-SR) groups after mTESE. Results: The mean age of the study population (n=58) was 35.53±6.10 years, and the mean infertility duration was 8.25±4.53 years. The mean serum AMH level was 2.42±2.35 ng/mL (median: 2.14 ng/mL; range: 0.01-9.87 ng/mL). +SR was achieved in 29 patients (50%), whereas no sperm could be retrieved in the remaining 29 patients (50%). Comparison of two groups revealed no statistically significant difference between the sperm-positive and sperm-negative groups with respect to age, duration of infertility, AMH, FSH, LH, testosterone, or the AMH/testosterone ratio. Receiver operating characteristic analysis revealed an area under the curve value of 0.531 for AMH (95% confidence interval: 0.379-0.683, p=0.690), indicating no significant predictive value. Binomial logistic regression analysis also found no variable to be a significant predictor of +SR. Conclusion: Serum AMH level, either alone or in combination with other hormonal parameters, was not found to be a reliable clinical biomarker for predicting SR outcomes in men with NOA undergoing mTESE. Larger, prospective, etiologically stratified studies are required to determine the definitive role of AMH in preoperative evaluation.

Authors

Institutions

Publication Details

Journal
Journal of Turkish Society of Obstetric and Gynecology
Published
2026-10-30
DOI
https://doi.org/10.4274/tjod.galenos.2026.47041
Primary Topic
Sperm and Testicular Function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship between pre-micro-TESE serum anti-Müllerian hormone (AMH) levels and sperm retrieval success in patients diagnosed with non-obstructive azoospermia: A retrospective study

Ayşen Yücetürk, Tansu Güdelci, Burak Elmas, Bülent Tıraş et al.
1 links
Journal of Turkish Society of Obstetric and Gynecology
Sperm and Testicular Function
article

Relationship between pre-micro-TESE serum anti-Müllerian hormone (AMH) levels and sperm retrieval success in patients diagnosed with non-obstructive azoospermia: A retrospective study

Ayşen Yücetürk, Tansu Güdelci, Burak Elmas, Bülent Tıraş, Özge Karaosmanoğlu, İlke Özer Aslan, Nuri Peker
article en

Abstract

Objective: We aimed to evaluate the relationship between serum anti-Müllerian hormone (AMH) levels measured before microdissection testicular sperm extraction (mTESE) and sperm retrieval (SR) success in men diagnosed with non-obstructive azoospermia (NOA). Materials and Methods: The present study was based on retrospective evaluation of 58 patients who presented to our clinic between January 2025 and April 2026, were diagnosed with NOA, and underwent mTESE. Patient age, duration of infertility, serum AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH) testosterone levels, and the AMH/testosterone ratio were recorded. Demographic and hormonal parameters were compared between the successful SR (+SR) and unsuccessful SR (-SR) groups after mTESE. Results: The mean age of the study population (n=58) was 35.53±6.10 years, and the mean infertility duration was 8.25±4.53 years. The mean serum AMH level was 2.42±2.35 ng/mL (median: 2.14 ng/mL; range: 0.01-9.87 ng/mL). +SR was achieved in 29 patients (50%), whereas no sperm could be retrieved in the remaining 29 patients (50%). Comparison of two groups revealed no statistically significant difference between the sperm-positive and sperm-negative groups with respect to age, duration of infertility, AMH, FSH, LH, testosterone, or the AMH/testosterone ratio. Receiver operating characteristic analysis revealed an area under the curve value of 0.531 for AMH (95% confidence interval: 0.379-0.683, p=0.690), indicating no significant predictive value. Binomial logistic regression analysis also found no variable to be a significant predictor of +SR. Conclusion: Serum AMH level, either alone or in combination with other hormonal parameters, was not found to be a reliable clinical biomarker for predicting SR outcomes in men with NOA undergoing mTESE. Larger, prospective, etiologically stratified studies are required to determine the definitive role of AMH in preoperative evaluation.

Journal of Turkish Society of Obstetric and Gynecology
Acıbadem University (TR)
Good health and well-being
Openalex Percentile: Top 11%
Sperm and Testicular Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon